WO2003018612A3 - Extracellular messengers - Google Patents

Extracellular messengers Download PDF

Info

Publication number
WO2003018612A3
WO2003018612A3 PCT/US2002/027213 US0227213W WO03018612A3 WO 2003018612 A3 WO2003018612 A3 WO 2003018612A3 US 0227213 W US0227213 W US 0227213W WO 03018612 A3 WO03018612 A3 WO 03018612A3
Authority
WO
WIPO (PCT)
Prior art keywords
exmes
extracellular messengers
messengers
polynucleotides
agonists
Prior art date
Application number
PCT/US2002/027213
Other languages
French (fr)
Other versions
WO2003018612A2 (en
Inventor
Brendan M Duggan
Original Assignee
Incyte Genomics Inc
Brendan M Duggan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc, Brendan M Duggan filed Critical Incyte Genomics Inc
Priority to EP02761511A priority Critical patent/EP1429806A2/en
Priority to JP2003523271A priority patent/JP2005508155A/en
Priority to CA002458445A priority patent/CA2458445A1/en
Priority to AU2002326769A priority patent/AU2002326769A1/en
Publication of WO2003018612A2 publication Critical patent/WO2003018612A2/en
Publication of WO2003018612A3 publication Critical patent/WO2003018612A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Abstract

Various embodiments of the invention provide human extracellular messengers (EXMES) and polynucleotides which identify and encode EXMES. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of EXMES.
PCT/US2002/027213 2001-08-24 2002-08-22 Extracellular messengers WO2003018612A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP02761511A EP1429806A2 (en) 2001-08-24 2002-08-22 Extracellular massengers
JP2003523271A JP2005508155A (en) 2001-08-24 2002-08-22 Extracellular messenger
CA002458445A CA2458445A1 (en) 2001-08-24 2002-08-22 Extracellular messengers
AU2002326769A AU2002326769A1 (en) 2001-08-24 2002-08-22 Extracellular messengers

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
US31481101P 2001-08-24 2001-08-24
US60/314,811 2001-08-24
US34058401P 2001-12-14 2001-12-14
US60/340,584 2001-12-14
US35059502P 2002-01-18 2002-01-18
US60/350,595 2002-01-18
US36343202P 2002-03-11 2002-03-11
US60/363,432 2002-03-11
US36460702P 2002-03-15 2002-03-15
US60/364,607 2002-03-15
US37076102P 2002-04-05 2002-04-05
US60/370,761 2002-04-05
US39137802P 2002-06-24 2002-06-24
US60/391,378 2002-06-24

Publications (2)

Publication Number Publication Date
WO2003018612A2 WO2003018612A2 (en) 2003-03-06
WO2003018612A3 true WO2003018612A3 (en) 2003-07-24

Family

ID=27569657

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/027213 WO2003018612A2 (en) 2001-08-24 2002-08-22 Extracellular messengers

Country Status (5)

Country Link
EP (1) EP1429806A2 (en)
JP (1) JP2005508155A (en)
AU (1) AU2002326769A1 (en)
CA (1) CA2458445A1 (en)
WO (1) WO2003018612A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2524309T3 (en) * 2004-04-20 2014-12-05 Sphingotec Gmbh Use of tachykinin precursors and / or their fragments in medical diagnosis
EP1828241A1 (en) 2004-12-23 2007-09-05 Laboratoires Serono S.A. G-csf polypeptides and uses thereof
WO2023246840A1 (en) * 2022-06-22 2023-12-28 Wuhan Houxian Biopharmaceutical Co. Ltd. Combination of il-12 and ox40l for cancer immunotherapy

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830451A (en) * 1996-07-19 1998-11-03 Brigham & Women's Hospital, Inc. Haematopoietic cytokine Epstein Barr virus-induced protein

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830451A (en) * 1996-07-19 1998-11-03 Brigham & Women's Hospital, Inc. Haematopoietic cytokine Epstein Barr virus-induced protein

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] US NATIONAL LIBRARY OF MEDICINE, (BETHESDA, MD, USA); 10 June 1998 (1998-06-10), NCI-CGAP, XP002962850, accession no. NCBI Database accession no. (AA913336) *

Also Published As

Publication number Publication date
AU2002326769A1 (en) 2003-03-10
EP1429806A2 (en) 2004-06-23
CA2458445A1 (en) 2003-03-06
JP2005508155A (en) 2005-03-31
WO2003018612A2 (en) 2003-03-06

Similar Documents

Publication Publication Date Title
WO2001098351A3 (en) G-protein coupled receptors
WO2003052075A3 (en) Enzymes
WO2003027228A3 (en) Receptors and membrane-associated proteins
WO2001057085A3 (en) G-protein coupled receptors
WO2001087937A3 (en) G-protein coupled receptors
WO2001098354A3 (en) Human receptors
WO2003048305A3 (en) Receptors and membrane-associated proteins
WO2001098323A3 (en) G-protein coupled receptors
WO2003042357A3 (en) Enzymes
WO2003031568A3 (en) Intracellular signaling molecules
WO2001072836A3 (en) G-protein coupled receptors
WO2002026825A3 (en) G-protein coupled receptors
WO2001090359A3 (en) G-protein coupled receptors
WO2003062391A3 (en) Structural and cytoskeleton-associated proteins
WO2003047526A3 (en) Cell adhesion and extracellular matrix proteins
WO2001066742A3 (en) G-protein coupled receptors
WO2002101008A3 (en) Intracellular signaling molecules
WO2002063004A3 (en) G-protein coupled receptors
WO2003025130A3 (en) Receptors and membrane-associated proteins
WO2001092527A3 (en) Regulators of apoptosis
WO2002066646A3 (en) Neurotransmission-associated proteins
WO2003039348A3 (en) Intracellular signaling molecules
WO2003018612A3 (en) Extracellular messengers
WO2001094587A3 (en) Extracellular messengers
WO2003023009A3 (en) G-protein coupled receptors

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE CH CY DE DK FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2458445

Country of ref document: CA

Ref document number: 2003523271

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002761511

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002761511

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2002761511

Country of ref document: EP